AVE Science & Technology Co Ltd - Asset Resilience Ratio
AVE Science & Technology Co Ltd (688067) has an Asset Resilience Ratio of 24.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688067 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how AVE Science & Technology Co Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of AVE Science & Technology Co Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down AVE Science & Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688067 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥147.54 Million | 24.13% |
| Total Liquid Assets | CN¥147.54 Million | 24.13% |
Asset Resilience Insights
- Good Liquidity Position: AVE Science & Technology Co Ltd maintains a healthy 24.13% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
AVE Science & Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare AVE Science & Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 23.52% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Sartorius Aktiengesellschaft
XETRA:SRT3 |
Medical Instruments & Supplies | 4.48% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for AVE Science & Technology Co Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for AVE Science & Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.18% | CN¥17.86 Million ≈ $2.61 Million |
CN¥561.00 Million ≈ $82.09 Million |
+2.28pp |
| 2023-12-31 | 0.90% | CN¥5.01 Million ≈ $732.63K |
CN¥556.69 Million ≈ $81.46 Million |
-22.31pp |
| 2022-12-31 | 23.21% | CN¥127.59 Million ≈ $18.67 Million |
CN¥549.65 Million ≈ $80.43 Million |
+11.34pp |
| 2021-12-31 | 11.87% | CN¥65.00 Million ≈ $9.51 Million |
CN¥547.61 Million ≈ $80.13 Million |
+0.07pp |
| 2020-12-31 | 11.80% | CN¥35.00 Million ≈ $5.12 Million |
CN¥296.57 Million ≈ $43.40 Million |
-- |
About AVE Science & Technology Co Ltd
AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more